Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Drug-induced liver injury: mechanisms, types and biomarkers.

Vinken M, Maes M, Vanhaecke T, Rogiers V.

Curr Med Chem. 2013;20(24):3011-21.

PMID:
23746274
2.

Drug-induced liver injury in 2007.

Norris W, Paredes AH, Lewis JH.

Curr Opin Gastroenterol. 2008 May;24(3):287-97. doi: 10.1097/MOG.0b013e3282f9764b. Review.

PMID:
18408456
3.

Idiosyncratic drug-induced liver injury: an overview.

Hussaini SH, Farrington EA.

Expert Opin Drug Saf. 2007 Nov;6(6):673-84. Review.

PMID:
17967156
4.

Central role of mitochondria in drug-induced liver injury.

Pessayre D, Fromenty B, Berson A, Robin MA, Lettéron P, Moreau R, Mansouri A.

Drug Metab Rev. 2012 Feb;44(1):34-87. doi: 10.3109/03602532.2011.604086. Epub 2011 Sep 6. Review.

PMID:
21892896
5.

Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.

Kumar BS, Chung BC, Kwon OS, Jung BH.

J Appl Toxicol. 2012 Jul;32(7):505-20. doi: 10.1002/jat.1746. Epub 2011 Dec 1.

PMID:
22131085
6.

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.

Beger RD, Sun J, Schnackenberg LK.

Toxicol Appl Pharmacol. 2010 Mar 1;243(2):154-66. doi: 10.1016/j.taap.2009.11.019. Epub 2009 Nov 22. Review.

PMID:
19932708
7.

Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies.

Labbe G, Pessayre D, Fromenty B.

Fundam Clin Pharmacol. 2008 Aug;22(4):335-53. doi: 10.1111/j.1472-8206.2008.00608.x. Review.

PMID:
18705745
8.

Drug-induced liver injury.

Kaplowitz N.

Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S44-8.

PMID:
14986274
9.

Diagnosis, management and prevention of drug-induced liver injury.

Verma S, Kaplowitz N.

Gut. 2009 Nov;58(11):1555-64. doi: 10.1136/gut.2008.163675.

PMID:
19834119
10.

[The diagnosis of drug-induced hepatopathies].

Oancea R.

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989 Jan-Feb;41(1):1-13. Review. Romanian.

PMID:
2573920
11.

[Drug- and toxin-induced hepatotoxicity].

Grünhage F, Fischer HP, Sauerbruch T, Reichel C.

Z Gastroenterol. 2003 Jun;41(6):565-78. Review. German.

PMID:
12806543
12.

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.

Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B.

J Hepatol. 2011 Apr;54(4):773-94. doi: 10.1016/j.jhep.2010.11.006. Epub 2010 Nov 17. Review.

13.

Drug hepatotoxicity.

Timbrell JA.

Br J Clin Pharmacol. 1983 Jan;15(1):3-14. Review. No abstract available.

14.

An algorithm for monitoring and managing drug hepatotoxicity.

Hofmann AF, Thistle JL.

Gastroenterology. 1974 Aug;67(2):309-13. No abstract available.

PMID:
4847711
15.

[Hepatotoxicity associated with the use of Herbalife].

Jóhannsson M, Ormarsdóttir S, Olafsson S.

Laeknabladid. 2010 Mar;96(3):167-72. Icelandic.

PMID:
20197595
16.

Clinical correlations in alcoholic patients without manifest cirrhosis.

Bordalo O, Batista A, Geraldes J, Neto F, Mascarenhas F, Leitao N, Noronha M, Lamy J, Silva PE.

Am J Gastroenterol. 1974 May;61(5):371-8. No abstract available.

PMID:
4835934
17.

Observations on hepatic histology and function in alcoholic dogs.

Chey WY, Kosay S, Siplet H, Lorber SH.

Am J Dig Dis. 1971 Sep;16(9):825-38. No abstract available.

PMID:
5107143
19.

A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage.

Kim JS, Jang YR, Lee JW, Kim JY, Jung YK, Chung DH, Kwon OS, Kim YS, Choi DJ, Kim JH.

Korean J Hepatol. 2011 Sep;17(3):229-32. doi: 10.3350/kjhep.2011.17.3.229.

20.

Biochemical mechanisms in drug-induced liver injury: certainties and doubts.

Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P.

World J Gastroenterol. 2009 Oct 21;15(39):4865-76. Review.

Supplemental Content

Support Center